Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Gustafson Kurt A
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   535,630    

Indirect Shares

   11,840      
Direct Value   $2,769,477    

Indirect Value

   $12,195      
Total Shares   547,470      
Total Value   $2,781,673      


Halozyme Therapeutics Inc $1,498,371 Spectrum Pharmaceuticals Inc $326,777 OmniAb, Inc $802,204 Xencor Inc $142,126 Halozyme Therapeutics Inc $1,498,371 Spectrum Pharmaceuticals Inc $326,777 OmniAb, Inc $802,204 Xencor Inc $142,126
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    3    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   1.0   
   -3.0   
     Percentage Gain/Loss :
   103.1%
 -28.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Halozyme Therapeutics Inc HALO Vice President and CFO 2013-02-02 35,667 2011-08-09 0    Premium*  
            Spectrum Pharmaceuticals Inc SPPI EVP & Chief Financial ... 2022-03-16 317,259 2022-03-16 11,840    Premium*  
            OmniAb, Inc OABI Executive VP, Finance ... 2024-04-08 176,697 2022-11-01 0    Premium*  
            Xencor Inc XNCR Director 2024-03-06 6,007 2023-06-20 0    Premium*  
* Premium Members only  

Records found :    64         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-03-26 4 AS $9.90 $9,167 D/D (926) 246,714 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-03-26 4 AS $17.38 $22,594 D/D (1,300) 191,543 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-25 4 D $6.61 $9,320 D/D (1,410) 135,338 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2016-03-25 4 D $5.96 $9,089 D/D (1,525) 144,495 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-01-17 4 AS $3.33 $5,398 D/D (1,621) 231,955 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2021-01-20 4 AS $4.31 $8,379 D/D (1,944) 330,608 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-02-18 4 D $5.91 $14,604 D/D (2,471) 139,567 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-01-16 4 AS $3.37 $8,492 D/D (2,522) 233,576 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2021-01-19 4 AS $3.81 $9,832 D/D (2,582) 332,552 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-03-22 4 AS $18.13 $47,868 D/D (2,640) 192,843 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2016-02-18 4 D $4.55 $12,144 D/D (2,669) 119,030 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-22 4 D $6.42 $18,098 D/D (2,819) 136,748 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2015-02-18 4 D $7.23 $20,765 D/D (2,872) 131,766 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2016-03-22 4 D $6.08 $18,301 D/D (3,010) 146,020 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-04-01 4 AS $2.23 $6,991 D/D (3,135) 360,830 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-01-16 4 AS $10.44 $33,471 D/D (3,207) 216,896 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-02-20 4 AS $2.85 $9,499 D/D (3,333) 205,111 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-03-25 4 AS $9.46 $35,931 D/D (3,797) 247,640 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2021-02-22 4 AS $3.73 $14,920 D/D (4,000) 437,134 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-03-31 4 AS $2.31 $9,989 D/D (4,326) 363,965 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-03-28 4 AS $16.35 $71,123 D/D (4,350) 187,193 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-04-01 4 AS $10.73 $49,940 D/D (4,642) 236,098 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2021-02-19 4 AS $3.64 $16,992 D/D (4,672) 441,134 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-28 4 D $6.69 $31,530 D/D (4,713) 180,788 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-02-19 4 AS $2.77 $13,115 D/D (4,733) 208,444 0 %
  64  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us